The degree to which individuals (health professionals or patients) can obtain, comprehend, communicate, calculate and process patient-specific information about biosimilar medicines, to make informed medication and health decisions in order to safely and effectively prescribe, dispense or use biosimilars.
Last update: 4 June 2025
Source: PPRI, adapted from Pouliot et al. 2018